Bifeprunox: beneficial in schizophrenia?

By  

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Sertindole, a useful option in the treatment of schizophrenia, is not associated with an excess of overall mortality

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 12, 2006-12 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Switching Patients with Stable Schizophrenia or Schizoaffective Disorder from Olanzapine to Risperidone Long-Acting Injectable

By Rosa Fernanda  

Clinical Drug Investigation, Vol. 32, Iss. 4, 2012-04 ,pp. : 267-279

Adis International

Access to resources Recommend Favorite

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine

By Chrzanowski Wlodzimierz   Marcus Ronald   Torbeyns Anne   Nyilas Margaretta   McQuade Robert  

Psychopharmacology, Vol. 189, Iss. 2, 2006-12 ,pp. : 259-266

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenomics and schizophrenia

By Kawanishi Y.   Tachikawa H.   Suzuki T.  

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 227-241

Elsevier

Access to resources Recommend Favorite